Efficacy and Safety of Fentanyl in Combination with Midazolam in Children on Mechanical Ventilation

Area of Science:

• Pediatric Critical Care Medicine
• Pharmacology
• Clinical Anesthesiology

Background:

• Mechanical ventilation in children necessitates effective sedation strategies.
• Optimizing sedation is crucial for patient comfort and clinical outcomes.
• Fentanyl is a potent opioid analgesic with sedative properties.

Purpose of the Study:

• To assess the efficacy and safety of fentanyl as an adjunct to midazolam for sedation in pediatric patients requiring mechanical ventilation.
• To compare sedation effectiveness and adverse events between midazolam monotherapy and fentanyl-midazolam combination therapy.

Main Methods:

• A double-blind, randomized controlled trial involving pediatric patients (2 months to 18 years) on mechanical ventilation.
• Patients were randomized to receive either midazolam alone (control) or fentanyl plus midazolam (combination group).
• Sedation levels were monitored using the Comfort Behavior Scale (CBS), with infusion rates adjusted based on CBS scores.

Main Results:

• The fentanyl-midazolam combination group showed a significantly lower incidence of under-sedation (CBS difference ≥ 4 points) compared to midazolam alone (P < 0.001).
• Serious under-sedation events (CBS difference ≥ 8 points) were also significantly reduced in the combination group (P < 0.001).
• The combination therapy resulted in a lower cumulative midazolam dose and did not increase major fentanyl-related adverse events.

Conclusions:

• Fentanyl in combination with midazolam provides more effective sedation for mechanically ventilated children than midazolam alone.
• This combination therapy is safe and well-tolerated in the pediatric population.
• The findings support the use of fentanyl-midazolam for optimizing sedation in critically ill children.